ACY-1215 combined with the BRD4 inhibitor (JQ1) inhibited the growth of xenograft tumors from small cell lung cancer cells by stimulating NK cell-mediated immune activity [24]. This evidence concerns the gene BRD4 and small cell lung carcinoma.